Federal Official Gazette
ANS NORMATIVE RESOLUTION No. 654, OF DECEMBER 12, 2025.
Amends Annexes I and II of Normative Resolution (RN) No. 465, of February 24, 2021, which provides for the List of Health Procedures and Events (Rol) within the scope of Supplementary Health, to incorporate the procedure ROBOT-ASSISTED RADICAL PROSTATECTOMY (WITH UTILIZATION GUIDELINE) for the treatment of patients with localized or locally advanced prostate cancer, in compliance with paragraphs 4 and 10 of Article 10 of Law No. 9,656/1998.
ANS NORMATIVE RESOLUTION No. 655, OF DECEMBER 12, 2025.
Amends Normative Resolution (RN) No. 465, of February 24, 2021, which provides for the List of Health Procedures and Events (Rol) within the scope of Supplementary Health, to regulate the mandatory coverage of the immunobiological drug guselcumab, for the treatment of adult patients with moderate to severe ulcerative colitis after failure, refractoriness, relapse or intolerance to anti-TNF therapy, in compliance with paragraphs 4, 7 and 8 of Article 10 of Law No. 9,656/1998.
ANS news
ANS holds Public Hearing 62
Proposals to incorporate cancer and heart condition treatments into the Rol will be debated on Dec 18, 2025
https://www.gov.br/ans/pt-br/assuntos/noticias/sociedade/ans-promove-audiencia-publica-62
ANS Chairman is the guest on the new episode of ANS em Pauta
The program covers Wadih Damous’s view on the challenges and paths to strengthen regulation
“We must have a combination of boldness and creativity in the regulatory process. What cannot exist is a limited outlook. We need to tackle the issues that remain unresolved, to talk about price adjustment, termination of contracts, disease prevention, always with transparency and responsibility,” he says.
Open public consultations
- CP 164. Public Consultation (CP) No. 164 aims to receive contributions on the preliminary recommendations related to health technologies proposed internally by ANS, originating from the incorporations of technologies into the Unified Health System (SUS) recommended by the National Commission for the Incorporation of Technologies in the SUS (CONITEC), carried out between May 2, 2019 and Sep 2, 2021. These proposed updates to the Rol are being presented in accordance with Article 38 of RN No. 555, of 2022. The consultation also submits to public participation the Preliminary Report resulting from the 43rd technical meeting of the Commission for the Update of the List of Procedures and Events in Supplementary Health (COSAÚDE), in compliance with Article 10, § 11, item III, of Law No. 9,656/1998, added by Law No. 14,307, of 2022, and Article 26 of RN No. 555, of 2022. Deadline: Dec 23, 2025.
- CP 165. Aims to receive contributions on the proposed Normative Resolution that provides for the transfer of portfolios of private health care plans between private health care plan operators. Deadline: Jan 23, 2026.
- CP 166. Aims to receive contributions on the preliminary recommendation of non-incorporation for the technologies contained in UATs No. 178, 179 and 182. Deadline: Dec 30, 2025.
Scheduled public hearings
-AP 62. Collection of contributions on the preliminary recommendation of non-incorporation for the following technologies: (i) UAT 178 – Surgical exclusion of the left atrial appendage (LAA), by means of a surgical clip, concomitant with open heart surgery for patients with atrial fibrillation or at high risk of stroke, as measured by the CHA2DS2-VASc score > 2; (ii) UAT 179 – Cabozantinib levomalate for patients with well-differentiated, unresectable, locally advanced or metastatic neuroendocrine tumors, previously treated with two or more therapies; and (iii) UAT 182 – Enzalutamide + Androgen deprivation therapy (ADT) for the treatment of non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence. Date: Dec 18, 2025, from 9 a.m. to 1 p.m.
Open public calls for input
There are no open public calls for input.
Open public calls
No updates.
Other news
Initial claim denials (glosas) soar and choke hospitals’ cash flow
Source: terra.com.br · read the full article
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.